You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Litigation Details for Ravgen, Inc. v. Myriad Genetics, Inc. (D. Del. 2020)


✉ Email this page to a colleague

« Back to Dashboard


Biologic Drugs cited in Ravgen, Inc. v. Myriad Genetics, Inc.

The biologic drugs covered by the patent cited in this case are ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , and ⤷  Try a Trial .

Details for Ravgen, Inc. v. Myriad Genetics, Inc. (D. Del. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-12-20 1 Complaint United States Patent Nos. 7,727,720 (the “’720 Patent”) and 7,332,277 (the “’277 Patent”) (collectively…number of patents and patent applications that are related to subject matter similar to the Patents-in-Suit…collectively the “Patents-in-Suit”), arising under the Patent Laws of the United States, 35 U.S.C. §§ 271 et …resulted in the issuance of several patents, including the Patents-in-Suit. 3. Defendant…United States Patent and Trademark Office on February 19, 2008. The inventor of the patent is Ravinder External link to document
2020-12-20 3 Patent/Trademark Report to Commissioner of Patents HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 US 7,727,720 B2 …Trademarks or ✔ Patents. G ( G the patent action involves…Women’s Health, Inc. PATENT OR DATE OF PATENT …G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office External link to document
2022-03-08 75 Stipulation one pending inter partes review of U.S. Patent Nos. 7,727,720 and 7,332,277 (IPR2021-00788, IPR2021-00791…Proceedings”)), which IPR Proceedings address every patent claim asserted by Ravgen against Myriad in this…2020 1 November 2023 1:20-cv-01730 830 Patent Plaintiff District Court, D. Delaware External link to document
2022-03-14 76 SO ORDERED one pending inter partes review of U.S. Patent Nos. 7,727,720 and 7,332,277 (IPR2021-00788, IPR2021-00791…Proceedings”)), which IPR Proceedings address every patent claim asserted by Ravgen against Myriad in this…2020 1 November 2023 1:20-cv-01730 830 Patent Plaintiff District Court, D. Delaware External link to document
2021-02-10 9 Answer to Complaint what appears to be a copy of U.S. Patent No. 7,727,720 (“the ’720 patent”) was attached to the Complaint…purports to assert a claim for alleged patent infringement under the patent laws of the United States, 35 U.S.C…what appears to be a copy of U.S. Patent No. 7,332,277 (“the ‘277 patent”) was attached to the Complaint…of the ’277 patent and to Exhibit 2 of the Complaint for the content of the ’720 patent. Myriad denies…of the ’277 patent and to Exhibit 2 of the Complaint for the content of the ’720 patent. Myriad denies External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.